Overview

Smart Insulin Pens Market is estimated to value over USD 137 million by 2027 end and register a CAGR of over 10.8% during the forecast period 2020 to 2027.

A rise in the presence of diabetic conditions raises the insistence for needle-free insulin delivery devices that are needle-free. As per the Centers for Disease Control and Prevention (CDC), approximately 30 million people or over 9% of the total population of the United States suffered from diabetes in 2015. Additionally, as per the Diabetes UK, in 2017, over 3.2 million people were diabetes patients. Therefore, an increase in diabetes-related conditions is projected to have a positive influence on the smart insulin pens market growth.

The Asia Pacific market is predicted to expand the smart insulin pens market size with a high growth rate over the forecast period, owing to a rise in the ageing population who have more chances of getting diagnosed with diabetes. The Asia-Pacific region offers profitable opportunities for market proliferation, owing to its ever-increasing population base and increase in the prevalence of diabetic patients. Additionally, low device costs as compared to traditional insulin pen shall further increase the insistence of smart insulin pens in the Asia Pacific region.

Key market players included in smart insulin pens industry are Novo Nordisk, Sanofi, Eli Lilly and Co., Companion Medical, Emperra GmbH E-Health Technologies, Diabnext, Jiangsu Delfu Medical Device Co. Ltd., Berlin Chemie, Diamesco Co. Ltd., Patients Pending Ltd. 

Smart Insulin Pens Market Market Segmentation:

By Product

• Smart Insulin Pen
• Adaptors for Conventional Pen

By Connectivity

• Bluetooth
• USB

By Diabetes Type

• Type 1 Diabetes
• Type 2 Diabetes

By Distribution Channel

• Hospital Pharmacy
• Online Sales
• Retail Pharmacy
• Diabetes Clinics/Centres

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the market by product, by connectivity, by diabetes type, by distribution channel and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, industry-specific restraints and opportunities)
• To forecast and evaluate micro-markets and the overall market 
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
• To record, evaluate and analyse competitive landscape mapping- technological advancements, product launches, expansions and mergers

Table of Contents

1. Market Introduction

      1.1 Objectives of the Study 
      1.2 Market Definition 
      1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered

      1.4 Currency   
      1.5 Limitations 
      1.6 Stakeholders 

2.  Research Methodology 

       2.1 Research Data 
              2.1.1 Secondary Data
                 2.1.1.1 Key Data From Secondary Sources
             2.1.2 Primary Data
                 2.1.2.1 Key Data From Primary Sources
       2.2 Market Size Estimation 
       2.3 Market Breakdown and Data Triangulation 
       2.4 Assumptions for the Study  

3. Executive Summary
        3.1 Market Outlook
        3.2 Segment Outlook
        3.3 Competitive Insights
4. Global Smart Insulin Pens Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards And Compliances
5. Market Overview
     5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Smart Insulin Pens Market Analysis Tools
         6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
         6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
         6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
         6.4. Market Entry Strategies
         6.5. Case Studies
7. Global Smart Insulin Pens Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
           7.1. Smart Insulin Pen
           7.2. Adaptors for Conventional Pen
8. Global Smart Insulin Pens Market, By Connectivity Historical Analysis and Forecast 2020-2027 (USD Million)
           8.1. Bluetooth
           8.2. USB
9. Global Smart Insulin Pens Market, By Diabetes Type Historical Analysis and Forecast 2020-2027 (USD Million)
           9.1. Type 1 Diabetes
           9.2. Type 2 Diabetes
10. Global Smart Insulin Pens Market, By Distribution Channel Historical Analysis and Forecast 2020-2027 (USD Million)
           10.1. Hospital Pharmacy
           10.2. Online Sales
           10.3. Retail Pharmacy
           10.4. Diabetes Clinics/Centres
11.  North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) along with expected regulatory needs
     11.1. Introduction
     11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            11.2.1. U.S.A
            11.2.2. Canada
            11.2.3. Mexico
     11.3. Market Size (USD Million) Forecast for North America 2020-2027
12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
     12.1. Introduction
     12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
           12.2.1. Germany
           12.2.2. U.K
           12.2.3. France
           12.2.4. Italy
           12.2.5. Spain
           12.2.6. Russia
           12.2.7. Poland
           12.2.8. Switzerland
           12.2.9. Rest of Western Europe
13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) - along with expected regulatory needs
        13.1. Introduction
        13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 
             13.2.1. Japan
             13.2.2. China
             13.2.3. Singapore
             13.2.4. India
             13.2.5. Australia and New Zealand
             13.2.6. ASEAN
             13.2.7. South Korea
             13.2.8. Rest of Asia Pacific
        13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
14. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 
                       14.1. Introduction
                       14.2. Regional Market Trends
                       14.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            14.3.1. Brazil
            14.3.2. Venezuela
            14.3.3. Argentina
            14.3.4. Rest of Latin America
                        14.4. Market Size (USD Million) Forecast for Latin America 2020-2027
15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
15.1. Introduction
15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
               15.2.1. Saudi Arabia
             15.2.2. UAE
             15.2.3. South Africa
             15.2.4. Egypt
15.3. Market Size (USD Million) Forecast for MEA 2020-2027
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
         16.1. Novo Nordisk
                16.1.1. Company Overview
                 16.1.2. Product Portfolio
                16.1.3. SWOT Analysis
                16.1.4. Financial Overview
                16.1.5. Strategic Overview
         16.2. Sanofi
                16.2.1. Company Overview
                16.2.2. Product Portfolio
                16.2.3. SWOT Analysis
                16.2.4. Financial Overview
                16.2.5. Strategic Overview
         16.3. Eli Lilly and Co.
                16.3.1. Company Overview
                16.3.2. Product Portfolio
                16.3.3. SWOT Analysis
                16.3.4. Financial Overview
                16.3.5. Strategic Overview
         16.4. Companion Medical
                16.4.1. Company Overview
                16.4.2. Product Portfolio
                16.4.3. SWOT Analysis
                16.4.4. Financial Overview
                16.4.5. Strategic Overview
         16.5. Emperra GmbH E-Health Technologies
                16.5.1. Company Overview
                16.5.2. Product Portfolio
                16.5.3. SWOT Analysis
                16.5.4. Financial Overview
                16.5.5. Strategic Overview
         16.6. Diabnext
                16.6.1. Company Overview
                16.6.2. Product Portfolio
                16.6.3.  SWOT Analysis
                16.6.4. Financial Overview
                16.6.5. Strategic Overview
         16.7. Jiangsu Delfu Medical Device Co. Ltd.
                16.7.1. Company Overview
                16.7.2. Product Portfolio
                16.7.3. SWOT Analysis
                16.7.4. Financial Overview
                16.7.5. Strategic Overview
         16.8. Berlin Chemie
                16.8.1. Company Overview
                16.8.2. Product Portfolio
                16.8.3. SWOT Analysis
                16.8.4. Financial Overview
                16.8.5. Strategic Overview
         16.9. Diamesco Co. Ltd.
                16.9.1. Company Overview
                16.9.2. Product Portfolio
                16.9.3. SWOT Analysis
                16.9.4. Financial Overview
                16.9.5. Strategic Overview
         16.10. Patients Pending Ltd.
                16.10.1. Company Overview
                16.10.2. Product Portfolio
                16.10.3.  SWOT Analysis
                16.10.4. Financial Overview
                16.10.5. Strategic Overview
17. FutureWise SME key takeaway points for Client

Tables

Figures